SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Stevens DA, Williams GR 1999 Hormone regulation of chondrocyte differentiation and endochondral bone formation. Mol Cell Endocrinol 151:195204.
  • 2
    Karsenty G 2001 Chondrogenesis just ain't what it used to be. J Clin Invest 107:405407.
  • 3
    Hiraki Y, Inoue H, Iyama K, Kamizono A, Ochiai M, Shukunami C, Iijima S, Suzuki F, Kondo J 1997 Identification of chondromodulin I as a novel endothelial cell growth inhibitor. Purification and its localization in the avascular zone of epiphyseal cartilage. J Biol Chem 272:3241932426.
  • 4
    Cheung WH, Lee KM, Fung KP, Lui PY, Leung KS 2001 TGF-beta1 is the factor secreted by proliferative chondrocytes to inhibit neo-angiogenesis. J Cell Biochem 36(Suppl):7988.
  • 5
    Moses MA, Wiederschain D, Wu I, Fernandez CA, Ghazizadeh V, Lane WS, Flynn E, Sytkowski A, Tao T, Langer R 1999 Troponin I is present in human cartilage and inhibits angiogenesis. Proc Natl Acad Sci USA 96:26452650.
  • 6
    Alini M, Marriott A, Chen T, Abe S, Poole AR 1996 A novel angiogenic molecule produced at the time of chondrocyte hypertrophy during endochondral bone formation. Dev Biol 176:124132.
  • 7
    Horner A, Bishop NJ, Bord S, Beeton C, Kelsall AW, Coleman N, Compston JE 1999 Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage. J Anat 194:519524.
  • 8
    Carlevaro MF, Albini A, Ribatti D, Gentili C, Benelli R, Cermelli S, Cancedda R, Cancedda FD 1997 Transferrin promotes endothelial cell migration and invasion: Implication in cartilage neovascularization. J Cell Biol 136:13751384.
  • 9
    DeSimone DP, Reddi AH 1992 Vascularization and endochondral bone development: Changes in plasminogen activator activity. J Orthop Res 10:320324.
  • 10
    Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z 1998 MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes Cell 93:411422.
  • 11
    Schipani E, Lanske B, Hunzelman J, Luz A, Kovacs CS, Lee K, Pirro A, Kronenberg HM, Juppner H 1997 Targeted expression of constitutively active receptors for parathyroid hormone and parathyroid hormone-related peptide delays endochondral bone formation and rescues mice that lack parathyroid hormone-related peptide. Proc Natl Acad Sci USA 94:1368913694.
  • 12
    Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T 1997 Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755764.
  • 13
    Erlebacher A, Filvaroff E, Gitelman SE, Derynck R 1995 Toward a molecular understanding of skeletal development. Cell 80:371378.
  • 14
    Schenk RK, Spiro D, Wiener J 1967 Cartilage resorption in the tibial epiphyseal plate of growing rats. J Cell Biol 34:275291.
  • 15
    Solskolne WA 1979 The osteoclast-endothelium interface during bone resorption in the femurs of young rabbits. Cell Tissue Res 203:487492.
  • 16
    Parfitt AM 2000 The mechanism of coupling: A role for the vasculature. Bone 26:319323.
  • 17
    Nakagawa M, Kaneda T, Arakawa T, Morita S, Sato T, Yomada T, Hanada K, Kumegawa M, Hakeda Y 2000 Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts. FEBS Lett 473:161164.
  • 18
    Engsig MT, Chen QJ, Vu TH, Pedersen AC, Therkidsen B, Lund LR, Henriksen K, Lenhard T, Foged NT, Werb Z, Delaisse JM 2000 Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 151:879890.
  • 19
    Deckers MML, van der Pluijm G, Dooijewaard S, Kroon ME, van Hinsbergh VW, Papapoulos SE, Löwik C 2001 Effect of angiogenic and antiangiogenic compounds on the outgrowth of capillary structures from fetal mouse explants. Lab Invest 81:515.
  • 20
    Horton MA 1997 The alpha v beta 3 integrin “vitronectin receptor”. Int J Biochem Cell Biol 29:721725.
  • 21
    Eliceiri BP, Cheresh DA 2000 Role of alpha v integrins during angiogenesis. Cancer J Sci Am 6:S245S249.
  • 22
    Blavier L, Delaisse JM 1995 Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. J Cell Sci 108:36493659.
  • 23
    Haas TL, Madri JA 1999 Extracellular matrix-driven matrix metalloproteinase production in endothelial cells: Implications for angiogenesis. Trends Cardiovasc Med 9:7077.
  • 24
    Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M, Kuznetsov SA, Mankani M, Robey PG, Poole AR, Pidoux I, Ward JM, Birkedal-Hansen H 1999 MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99:8192.
  • 25
    Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD, Nishikawa S 1990 The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345:442444.
  • 26
    Wang ZQ, Ovitt C, Grigoriadis AE, Mohle-Steinlein U, Ruther U, Wagner EF 1992 Bone and haematopoietic defects in mice lacking c-fos. Nature 360:741745.
  • 27
    Grigoriadis AE, Wang ZQ, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, Wagner EF 1994 c-Fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266:443448.
  • 28
    Marks SC, Lane PW 1976 Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse. J Hered 67:1118.
  • 29
    Marks SCJ, Hermey DC 1996 Structure and development of bone. In: BilezikianJP, RaiszLG, RodanGA (eds.) Principles of Bone Biology. Academic press, San Diego, CA, USA, pp. 37.
  • 30
    van der Pluijm G, Vloedgraven H, Papapoulos SE, Löwik CWGM, Grzesik W, Kerr J, Robey PG 1997 Attachment characteristics and involvement of integrins in adhesion of breast cancer cell lines to extracellular bone matrix components. Lab Invest 77:665675.
  • 31
    Frith JC, Monkkonen J, Blackburn GM, Russell RG, Rogers MJ 1997 Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5′-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro. J Bone Miner Res 12:13581367.
  • 32
    Benford HL, Frith JC, Auriola S, Monkkonen J, Rogers MJ 1999 Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: Biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs. Mol Pharmacol 56:131140.
  • 33
    Felix R, Cecchini MG, Hofstetter W, Elford PR, Stutzer A, Fleisch H 1990 Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse. J Bone Miner Res 5:781789.
  • 34
    Felix R, Cecchini MG, Fleisch H 1990 Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology 127:25922594.
  • 35
    Begg SK, Radley JM, Pollard JW, Chisholm OT, Stanley ER, Bertoncello I 1993 Delayed hematopoietic development in osteopetrotic (op/op) mice. J Exp Med 177:237242.
  • 36
    Kerstens HM, Poddighe PJ, Hanselaar AG 1995 A novel in situ hybridization signal amplification method based on the deposition of biotinylated tyramine. J Histochem Cytochem 43:347352.
  • 37
    Deckers MML, Smits P, Karperien M, Tylzanowski P, Feng P, Parmelee D, Zhang J, Bouffard E, Gentz R, Lowik CW, Merregaert J 2001 Recombinant human extracellular matrix protein 1 inhibits alkaline phosphatase activity and mineralization of mouse embryonic metatarsals in vitro. Bone 28:1420.
  • 38
    Williams RJLL, Robertson D, Davies JS 1989 Identification of vascular endothelial cells in murine omentum using lectin,dolichos biflorus agglutinin: Possible applications in the study of angiogenesis. Histochem J 21:271278.
  • 39
    Ponder BAJ, Festing MFW, Wilkinson MM 1985 An allelic difference determines reciprocal patterns of expression of binding sites for dolichos biflorus lectin in inbred strains of mice. J Embryol Exp Morphol 87:229239.
  • 40
    van der Pluijm G, Most W, van der Wee-Pals LJ, de Groot H, Papapoulos SE, Löwik CWGM 1991 Two distinct effects of recombinant human tumor necrosis factor-alpha on osteoclast development and subsequent resorption of mineralized matrix. Endocrinology 129:15961604.
  • 41
    Barka T, Anderson PJ 1962 Histochemical method for acid phosphatase using hexazonium pararosalin as a coupler. J Histochem Cytochem 10:741753.
  • 42
    Buckwalter JA, Glimcher MJ, Cooper RR, Recker R 1995 Bone Biology; Part 1: Structure, blood supply, cells, matrix and mineralization. J Bone Joint Surg Am 77:12561275.
  • 43
    Ferguson C, Alpern E, Miclau T, Helms JA 1999 Does adult fracture repair recapitulate embryonic skeletal formation? Mech Dev 87:5766.
  • 44
    Bloom DW, Fawcett W 1994 Bone. In: BloomDW, editor. A Textbook of histology. 12 ed. Chapman, New York, pp. 212218.
  • 45
    Ryan AM, Eppler DB, Hagler KE, Bruner RH, Thomford PJ, Hall RL, Shopp GM, O'Neill CA 1999 Preclinical safety evaluation of rhuMAbVEGF, an antiangiogenic humanized monoclonal antibody. Toxicol Pathol 27:7886.
  • 46
    Ferrara N 1999 Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 56:794814.
  • 47
    Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N 1999 VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5:623628.
  • 48
    Pruneri G, Bertolini F, Soligo D, Carboni N, Cortelezzi A, Ferrucci PF, Buffa R, Lambertenghi-Deliliers G, Pezzella F 1999 Angiogenesis in myelodysplastic syndromes. Br J Cancer 81:13981401.
  • 49
    van Holten-Verzantvoort AT, Bijvoet OL, Cleton FJ, Hermans J, Kroon HM, Harinck HI, Vermey P, Elte JW, Neijt JP, Beex LV 1987 Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment. Lancet 2:983985.
  • 50
    Diel IJ, Solomayer EF, Costa SD, Gollan C, Goerner R, Wallwiener D, Kaufmann M, Bastert G 1998 Reduction in new metastases in breast cancer with adjuvant clodronate treatment. N Engl J Med 339:357363.
  • 51
    Sato M, Grasser W, Endo N, Akins R, Simmons H, Thompson DD, Golub E, Rodan GA 1991 Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 88:20952105.
  • 52
    Fleisch H 1998 Bisphosphonates: Mechanisms of action. Endocr Rev 19:80100.
  • 53
    Schenk R, Merz WA, Mühlbauer R, Russell RGG, Fleisch H 1973 Effect of ethane-1-hydorxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl2MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calcif Tissue Res 11:196214.
  • 54
    Marshall MJ, Holt I, Davie MW 1993 Osteoclast recruitment in mice is stimulated by (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate. Calcif Tissue Int 52:2125.
  • 55
    Marshall MJ, Wilson AS, Davie MW 1990 Effects of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate on mouse osteoclasts. J Bone Miner Res 5:955962.
  • 56
    Aharinejad S, Marks SCJ, Bock P, Mason-Savas A, MacKay CA, Larson EK, Jackson ME, Luftensteiner M, Wiesbauer E 1995 CSF-1 treatment promotes angiogenesis in the metaphysis of osteopetrotic (toothless, tl) rats. Bone 16:315324.
  • 57
    Boissier S, Ferreras M, Peyruchaud O, Magnetto S, Ebetino FH, Colombel M, Delmas P, Delaisse JM, Clezardin P 2000 Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases. Cancer Res 60:29492954.
  • 58
    Teronen O, Konttinen YT, Lindqvist C, Salo T, Ingman T, Lauhio A, Ding Y, Santavirta S, Sorsa T 1997 Inhibition of matrix metalloproteinase-1 by dichloromethylene bisphosphonate (clodronate). Calcif Tissue Int 61:5961.
  • 59
    Teronen O, Heikkila P, Konttinen YT, Laitinen M, Salo T, Hanemaaijer R, Teronen A, Maisi P, Sorsa T 1999 MMP inhibition and downregulation by bisphosphonates. Ann NY Acad Sci 878:453465.
  • 60
    Colnot CI, Helms JA 2001 A molecular analysis of matrix remodeling and angiogenesis during long bone development. Mech Dev 100:245250.
  • 61
    Gerber HP, Ferrara N 2000 Angiogenesis and bone growth. Trends Cardiovasc Med 10:223228.
  • 62
    Brumsen C, Hamdy NA, Papapoulos SE 1997 Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis. Medicine (Baltimore) 76:266283.
  • 63
    Schenk RK, Wiener J, Spiro D 1968 Fine structural aspects of vascular invasion of the tibial epiphyseal plate of growing rats. Acta Anat 69:117.
  • 64
    Lewinson D, Silbermann M 1992 Chondroclasts and endothelial cells collaborate in the process of cartilage resorption. Anat Rec 233:504514.
  • 65
    Hiraoka N, Apel IJ, Gyetko MR, Weiss SJ, Allen E 1998 Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95:365377.
  • 66
    Kroon ME, Koolwijk P, van Goor H, Weidle UH, Collen A, van der Pluijm G, van Hinsbergh VWM 1999 Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices. Am J Pathol 154:17311742.
  • 67
    Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D 2000 Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2:737744.